Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II open-label study of intracranial GA002 plus clozapine in refractory temporal and frontal lobe epilepsy
CTR20262517Phase 2Active
- Sponsor
- Jianda Jiuzhou
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clozapine in temporal lobe epilepsy (TLE), frontal lobe epilepsy (FLE), sponsored by Jianda Jiuzhou. Started Jul 2026; status: active.
02
Drugs
clozapine
03
Conditions
temporal lobe epilepsy (TLE)frontal lobe epilepsy (FLE)
Beyond the preview
Go deeper on CTR20262517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262517.